1-(溴甲基)-4-甲基环己烷 | 21857-32-9

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机溴化物
• 中文名称: 1-(溴甲基)-4-甲基环己烷
• 中文别名: 1-溴甲基-4-甲基环己烷
• 英文名称: 1-Bromomethyl-4-methylcyclohexane
• 英文别名: 4-methylcyclohexylmethyl bromide；1-Brommethyl-4-methyl-cyclohexan；1-(bromomethyl)-4-methylcyclohexane
• CAS: 21857-32-9
• 化学式: C₈H₁₅Br
• mdl: MFCD16657517
• 分子量: 191.111
• InChiKey: CGJQBQWGDRNEDA-UHFFFAOYSA-N

物化性质

• 沸点：
  82-83 °C(Press: 13 Torr)
• 密度：
  1.189±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  1-(溴甲基)-4-甲基环己烷 以61%的产率得到
  参考文献：
  名称：

  SOLLADIE, G.;ZIMMERMANN, R.;BARTSCH, R.;WALBORSKY, H. M., SYNTHESIS, BRD, 1985, N 6-7, 662-665

  摘要：

  DOI：
• 作为产物：
  描述：

  4-甲基环己烷甲酸 在 lithium aluminium tetrahydride 、 溴 、 三苯基膦 作用下， 生成 1-(溴甲基)-4-甲基环己烷
  参考文献：
  名称：

  Conformational preferences of some substituted methyl groups in cyclohexanes as studied by carbon-13 nuclear magnetic resonance

  摘要：

  AbstractLow temperature 13C NMR spectra of 80:20 mixtures of cis and trans‐4CH3CH3C6H10CH2X, where C6H10‐is 1, 4‐disubtituted cyclohexyl and X=Br, CN, OH, OCH3, Si(CH3)3, Sn(CH3)3, Pb(CH3)3 and HgOCOCH3 have been recorded. The signals of the trans (e, e) components were assigned from the ambient temperature spectra of C6H11CH2X and the established substituent effects of an equatorial methyl group in cyclohexane. Conformational equilibria of the cis (e, a⇄a, e) components were then computed from the intensities of the (remaining) signals (∼180 K) of the two conformational isomers. From these equilibria A values of CH2X were calculated, assuming additivity of conformational energies of CH3 and CH2X (the counter‐poise approach). In general, these values are very similar to the value of the CH3, although some trends do emerge. This study provides α, β, γ, and δ effects for a wide range of axial and equatorial CH2X groups.

  DOI：

  10.1002/mrc.1270150304

文献信息

• [EN] NITRILE COMPOUND AND ITS USE IN PEST CONTROL<br/>[FR] COMPOSE NITRILE ET SON UTILISATION POUR LE CONTROLE DES INSECTES ET ANIMAUX NUISIBLES
  申请人：SUMITOMO CHEMICAL CO

  公开号：WO2005063694A1

  公开（公告）日：2005-07-14

  The present invention provides a nitrile compound represented by the formula (I): wherein R represents C1-C4 fluoroalkyl, Q represents halogen, C1-C11 alkyl optionally substituted with halogen, C2-C6 alkenyl group optionally substituted with halogen, C2-C6 alkynyl optionally substituted with halogen, C3-C7 cycloalkyl optionally substituted with halogen or (C3-C7 cycloalkyl optionally substituted with halogen)C1-C4 alkyl, which has excellent control effect against pests.

  本发明提供了一种由式(I)表示的腈化合物：其中R代表C1-C4氟烷基，Q代表卤素，C1-C11烷基可选择地取代卤素，C2-C6烯基基团可选择地取代卤素，C2-C6炔基可选择地取代卤素，C3-C7环烷基可选择地取代卤素或(C3-C7环烷基可选择地取代卤素)C1-C4烷基，对害虫具有出色的控制效果。
• [EN] 2,6,7,8 SUBSTITUTED PURINES AS HDM2 INHIBITORS<br/>[FR] PURINES 2,6,7,8-SUBSTITUÉES UTILISÉES EN TANT QU'INHIBITEURS DE HDM2
  申请人：MERCK SHARP & DOHME

  公开号：WO2014120748A1

  公开（公告）日：2014-08-07

  The present invention provides 2,6,7,8 Substituted Purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.

  本发明提供如本文所述的2,6,7,8取代嘌呤或其药学上可接受的盐。代表性化合物可用作HDM2蛋白的抑制剂。还公开了包括上述化合物的药物组合物以及使用它们治疗癌症的潜在方法。
• Pharmaceutically active imidazole derivatives
  申请人：Burroughs Wellcome Co.

  公开号：US04284641A1

  公开（公告）日：1981-08-18

  The invention relates to a class of imidazoles substituted by cycloalkyl or cycloalkenyl which have pharmacological properties making them useful in medicine, in particular in the prophylaxis and treatment of thrombo-embolic disorders.

  这项发明涉及一类由环烷基或环烯基取代的咪唑类化合物，具有药理特性，使它们在医学上特别在预防和治疗血栓栓塞性疾病方面有用。
• [EN] 2,6,7 SUBSTITUTED PURINES AS HDM2 INHIBITORS<br/>[FR] PURINES 2,6,7 SUBSTITUÉES UTILISÉES EN TANT QU'INHIBITEURS DE HDM2
  申请人：MERCK SHARP & DOHME

  公开号：WO2014123882A1

  公开（公告）日：2014-08-14

  The present invention provides 2,6,7 substituted purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.

  本发明提供如上所述的2,6,7取代嘌呤或其药用可接受的盐。代表性化合物可用作HDM2蛋白的抑制剂。还披露了包括上述化合物的药物组合物以及使用它们治疗癌症的潜在方法。
• Treatment of shock
  申请人：Burroughs Wellcome Co.

  公开号：US04317830A1

  公开（公告）日：1982-03-02

  The invention relates to a class of imidazoles substituted by cycloalkyl or cycloalkenyl which have pharmacological properties making them useful in medicine, in particular in the prophylaxis and treatment of thrombo-embolic disorders, and also of shock and angina pectoris.

  本发明涉及一类由环烷基或环烯基取代的咪唑类化合物，其具有药理学性质，可用于医学中，特别是在预防和治疗血栓栓塞性疾病，休克和心绞痛方面。